Literature DB >> 28344069

Selective post-training time window for memory consolidation interference of cannabidiol into the prefrontal cortex: Reduced dopaminergic modulation and immediate gene expression in limbic circuits.

Matheus Teixeira Rossignoli1, Cleiton Lopes-Aguiar2, Rafael Naime Ruggiero3, Raquel Araujo Do Val da Silva4, Lezio Soares Bueno-Junior5, Ludmyla Kandratavicius6, José Eduardo Peixoto-Santos7, José Alexandre Crippa8, Jaime Eduardo Cecilio Hallak9, Antonio Waldo Zuardi10, Raphael Escorsim Szawka11, Janete Anselmo-Franci12, João Pereira Leite13, Rodrigo Neves Romcy-Pereira14.   

Abstract

The prefrontal cortex (PFC), amygdala and hippocampus display a coordinated activity during acquisition of associative fear memories. Evidence indicates that PFC engagement in aversive memory formation does not progress linearly as previously thought. Instead, it seems to be recruited at specific time windows after memory acquisition, which has implications for the treatment of post-traumatic stress disorders. Cannabidiol (CBD), the major non-psychotomimetic phytocannabinoid of the Cannabis sativa plant, is known to modulate contextual fear memory acquisition in rodents. However, it is still not clear how CBD interferes with PFC-dependent processes during post-training memory consolidation. Here, we tested whether intra-PFC infusions of CBD immediately after or 5h following contextual fear conditioning was able to interfere with memory consolidation. Neurochemical and cellular correlates of the CBD treatment were evaluated by the quantification of extracellular levels of dopamine (DA), serotonin, and their metabolites in the PFC and by measuring the cellular expression of activity-dependent transcription factors in cortical and limbic regions. Our results indicate that bilateral intra-PFC CBD infusion impaired contextual fear memory consolidation when applied 5h after conditioning, but had no effect when applied immediately after it. This effect was associated with a reduction in DA turnover in the PFC following retrieval 5days after training. We also observed that post-conditioning infusion of CBD reduced c-fos and zif-268 protein expression in the hippocampus, PFC, and thalamus. Our findings support that CBD interferes with contextual fear memory consolidation by reducing PFC influence on cortico-limbic circuits.
Copyright © 2017 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  C-fos; cannabidiol; contextual fear memory; dopamine; medial prefrontal cortex

Mesh:

Substances:

Year:  2017        PMID: 28344069     DOI: 10.1016/j.neuroscience.2017.03.019

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  11 in total

1.  Cannabis: A potential efficacious intervention for PTSD or simply snake oil?

Authors:  Alfonso Abizaid; Zul Merali; Hymie Anisman
Journal:  J Psychiatry Neurosci       Date:  2019-03-01       Impact factor: 6.186

2.  A time-dependent contribution of hippocampal CB1 , CB2 and PPARγ receptors to cannabidiol-induced disruption of fear memory consolidation.

Authors:  Ana Maria Raymundi; Thiago R da Silva; Aleksander R Zampronio; Francisco S Guimarães; Leandro J Bertoglio; Cristina A J Stern
Journal:  Br J Pharmacol       Date:  2020-01-21       Impact factor: 8.739

3.  Systemic Injections of Cannabidiol Enhance Acetylcholine Levels from Basal Forebrain in Rats.

Authors:  Eric Murillo-Rodríguez; Gloria Arankowsky-Sandoval; Nuno Barbosa Rocha; Rodrigo Peniche-Amante; André Barciela Veras; Sérgio Machado; Henning Budde
Journal:  Neurochem Res       Date:  2018-06-06       Impact factor: 3.996

Review 4.  Integrating Endocannabinoid Signaling and Cannabinoids into the Biology and Treatment of Posttraumatic Stress Disorder.

Authors:  Matthew N Hill; Patrizia Campolongo; Rachel Yehuda; Sachin Patel
Journal:  Neuropsychopharmacology       Date:  2017-07-26       Impact factor: 7.853

Review 5.  Cannabidiol and substance use disorder: Dream or reality.

Authors:  Saeideh Karimi-Haghighi; Yasaman Razavi; Daniela Iezzi; Andrew F Scheyer; Olivier Manzoni; Abbas Haghparast
Journal:  Neuropharmacology       Date:  2022-01-13       Impact factor: 5.273

6.  Pharmacological Comparisons Between Cannabidiol and KLS-13019.

Authors:  Douglas E Brenneman; Dean Petkanas; William A Kinney
Journal:  J Mol Neurosci       Date:  2018-08-14       Impact factor: 3.444

7.  Manual Hippocampal Subfield Segmentation Using High-Field MRI: Impact of Different Subfields in Hippocampal Volume Loss of Temporal Lobe Epilepsy Patients.

Authors:  Jose Eduardo Peixoto-Santos; Luciana Estefani Drumond de Carvalho; Ludmyla Kandratavicius; Paula Rejane Beserra Diniz; Renata Caldo Scandiuzzi; Roland Coras; Ingmar Blümcke; Joao Alberto Assirati; Carlos Gilberto Carlotti; Caio Cesar Marconato Simoes Matias; Carlos Ernesto Garrido Salmon; Antonio Carlos Dos Santos; Tonicarlo R Velasco; Marcio Flavio D Moraes; Joao Pereira Leite
Journal:  Front Neurol       Date:  2018-11-20       Impact factor: 4.003

8.  Fear conditioning and extinction induce opposing changes in dendritic spine remodeling and somatic activity of layer 5 pyramidal neurons in the mouse motor cortex.

Authors:  Zhiwei Xu; Avital Adler; Hong Li; Luis M Pérez-Cuesta; Baoling Lai; Wei Li; Wen-Biao Gan
Journal:  Sci Rep       Date:  2019-03-15       Impact factor: 4.379

Review 9.  Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders.

Authors:  María S García-Gutiérrez; Francisco Navarrete; Ani Gasparyan; Amaya Austrich-Olivares; Francisco Sala; Jorge Manzanares
Journal:  Biomolecules       Date:  2020-11-19

Review 10.  Forgetting Unwanted Memories: Active Forgetting and Implications for the Development of Psychological Disorders.

Authors:  Marco Costanzi; Beatrice Cianfanelli; Alessandro Santirocchi; Stefano Lasaponara; Pietro Spataro; Clelia Rossi-Arnaud; Vincenzo Cestari
Journal:  J Pers Med       Date:  2021-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.